» Articles » PMID: 28376280

Independent and Interactive Effects of OPRM1 and DAT1 Polymorphisms on Alcohol Consumption and Subjective Responses in Social Drinkers

Overview
Specialty Psychiatry
Date 2017 Apr 5
PMID 28376280
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The current study examined independent and interactive effects of polymorphisms of the mu opioid receptor gene (OPRM1, A118G) and variable number tandem repeats of the dopamine transporter gene (DAT1, SLC6A3) on alcohol consumption and subjective responses to alcohol in 127 young, healthy, social drinkers.

Methods: Participants completed an in-person assessment, which included self-reported alcohol drinking patterns and blood sampling for DNA, and in a second visit, a cumulative alcohol dosing procedure with subjective ratings across multiple time points and breath alcohol contents (0.03 to 0.1%). DNA was analyzed for OPRM1 AA versus AG/GG (*G) genotypes, DAT1 10-repeat allele (A10) versus 9 or lesser alleles (A9), and ancestral informative markers.

Results: There were significant epistatic interactions between OPRM1 and DAT1 genotypes. Subjective High Assessment Scale scores after alcohol consumption were highest in *G and A9 carriers, and lowest in *G and A10 carriers. Negative subjective effects were also highest in *G and A9 carriers. Effects were similar in a sensitivity analysis limited to Caucasian subjects. There were independent and epistatic interactions on drinking. The OPRM1 *G allele was independently associated with fewer heavy drinking days. The A9 allele was associated with a greater number of drinking days, which was attenuated in carriers of the *G allele.

Conclusions: These findings highlight the biological importance of interactions between these 2 genes and interactions between brain opioid and dopamine systems.

Citing Articles

OPRM1 Gene Polymorphism in Women with Alcohol Use Disorder.

Boron A, Suchanecka A, Chmielowiec K, Smiarowska M, Chmielowiec J, Stronska-Pluta A Int J Mol Sci. 2024; 25(5).

PMID: 38474311 PMC: 10931719. DOI: 10.3390/ijms25053067.


The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory....

Zamarripa C, Novak M, Weerts E, Vandrey R, Spindle T Front Pharmacol. 2022; 13:964749.

PMID: 36147331 PMC: 9486093. DOI: 10.3389/fphar.2022.964749.


Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial.

Schacht J, Hoffman M, Chen B, Anton R Pharmacogenomics J. 2021; 22(1):1-8.

PMID: 34381173 PMC: 8799481. DOI: 10.1038/s41397-021-00250-8.


Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial.

Anton R, Voronin K, Book S, Latham P, Randall P, Glen W Alcohol Clin Exp Res. 2020; 44(10):2084-2096.

PMID: 32772383 PMC: 8080431. DOI: 10.1111/acer.14431.


A Critical Review of Methods and Results in the Search for Genetic Contributors to Alcohol Sensitivity.

Schuckit M Alcohol Clin Exp Res. 2018; 42(5):822-835.

PMID: 29623680 PMC: 5916326. DOI: 10.1111/acer.13628.


References
1.
Ray L, Hutchison K . Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry. 2007; 64(9):1069-77. DOI: 10.1001/archpsyc.64.9.1069. View

2.
Buhler K, Gine E, Echeverry-Alzate V, Calleja-Conde J, Rodriguez de Fonseca F, Lopez-Moreno J . Common single nucleotide variants underlying drug addiction: more than a decade of research. Addict Biol. 2015; 20(5):845-71. DOI: 10.1111/adb.12204. View

3.
Zhang Y, Wang D, Johnson A, Papp A, Sadee W . Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem. 2005; 280(38):32618-24. DOI: 10.1074/jbc.M504942200. View

4.
Bond C, LaForge K, Tian M, Melia D, Zhang S, Borg L . Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A. 1998; 95(16):9608-13. PMC: 21386. DOI: 10.1073/pnas.95.16.9608. View

5.
Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S . The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J. 2002; 1(2):152-6. DOI: 10.1038/sj.tpj.6500026. View